Methylphenidate
Research News and Information

Sunday, November 08, 2009

[Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review]

19 Sep 2009 The data and the conclusions of the Cochrane review of drug therapy for the management of cancer related fatigue (CRF) is analysed and summarized in this report. Overall, data is weakened substantially by a high degree of heterogeneity that stems ... Read more...

Methylphenidate for giggle incontinence.

18 Aug 2009 PURPOSE: Giggle incontinence or enuresis risoria is a socially embarrassing problem characterized by involuntary and complete bladder emptying in response to laughter. To our knowledge the cause of giggle incontinence is unknown, although a ... Read more...

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder.

30 Jul 2009 Attention-deficit/hyperactivity disorder (ADHD) is one of the most common behavioral disorders in childhood. It continues into adulthood in up to 65% of patients. Methylphenidate (MPH) is one of the most commonly used pharmacological treatments for ... Read more...

Latest indexed articles for 'Methylphenidate'

These are the very latest articles for this heading:

• Age-related changes in motor subtle signs among girls and boys with ADHD. 11 Oct 2009
• Turbocharging the brain. 29 Sep 2009
• [Pharmaceutical treatment of cancer-associated fatigue--a survey of a Cochrane review] 19 Sep 2009
• Methylphenidate for giggle incontinence. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Editorial comment. 18 Aug 2009
• Stimulant use linked to sudden death in children without heart problems. 10 Aug 2009
• OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder. 30 Jul 2009
• Stimulant treatment reduces lapses in attention among children with ADHD: the effects of methylphenidate on intra-individual response time distributions. 30 Jul 2009
• Methylphenidate: abuse and dependence. Abuse confirmed in France. 30 Jul 2009
• A washout period needed before switching from a neuroleptic to an amphetamine. 30 Jul 2009
• Novel interdisciplinary analgesic program. 30 Jul 2009
• Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate. 10 Jul 2009
• Disagreements with implications: diverging discourses on the ethics of non-medical use of methylphenidate for performance enhancement. 4 Jul 2009
• Efficacy of reboxetine in the treatment of attention-deficit/hyperactivity disorder in boys with intolerance to methylphenidate: an open-label, 8-week, methylphenidate-controlled trial. 29 Jun 2009
• Behavioral response to methylphenidate challenge: influence of early life parental care. 29 Jun 2009
• Chronic preexposure to methylphenidate cross-sensitizes methamphetamine in male Japanese quail. 29 Jun 2009
• Side effects of methylphenidate in childhood cancer survivors: a randomized placebo-controlled trial. 29 Jun 2009
• Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD. 29 Jun 2009
• Methylphenidate has positive hypocholesterolemic and hypotriglyceridemic effects: new data. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Methylphenidate'

Definition: A central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE.

Chemical name: 2-Piperidineacetic acid, alpha-phenyl-, methyl ester

Registry Number: 113-45-1

Descriptor UI: D008774

Alternative terms: Methylphenidate; Dexmethylphenidate; Dexmethylphenidate Hydrochloride; Hydrochloride, Dexmethylphenidate; Focalin; Novartis Pharmaceutical Brand of Dexmethylphenidate Hydrochloride; Metadate; Equasym; Celltech Brand of Methylphenidate Hydrochloride; Methylphenidate Hydrochloride; Hydrochloride, Methylphenidate; Phenidylate; Ritalin; Novartis Brand 1 of Methylphenidate Hydrochloride; Ritaline; Cephalon Brand of Methylphenidate Hydrochloride; Ritalin-SR; Ritalin SR; Novartis Brand 2 of Methylphenidate Hydrochloride; Tsentedrin; Centedrin; Daytrana; Methylin; Mallinckrodt Brand of Methylphenidate Hydrochloride;

Allowable Qualifiers: administration & dosage; adverse effects; analogs & derivatives; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Pharmacological Action: Dopamine Uptake Inhibitors; Central Nervous System Stimulants;

Tree Number: D02.241.223.601.600; D03.383.621.460;

Online Note: use METHYLPHENIDATE to search PHENIDYLATE 1978-94

History Note: PHENIDYLATE was see METHYLPHENIDATE 1978-94